Recruiting

NCT Number: NCT06833450

Reliability of IUS in Crohn's Disease

Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD).

In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Crohn Disease (CD) Crohn Disease Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Inflammatory Bowel Diseases Intestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU d'Amiens

Amiens, 80054, France

Location status: Recruiting

Location contact

Mathurin Fumery, Pr

CONTACT

[email protected]

33+3 22 08 88 51

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Crohn's disease evolving for at least 1 months
Patient older than 18 years
Patient covered by French national health insurance
Written informed consent

Exclusion criteria

Pregnant women or breastfeeding
Minor
Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)

Treatment and study plan

Transabdominal intestinal ultrasound

Other

Transabdominal intestinal ultrasound

Primary outcomes

Number of different IUS parameters between two operators

Time frame: 1 year

To assess in patients with CD the variability of IUS parameters between two operators

Study contacts

Contact information is provided by the study sponsor or research team.

Mathurin Fumery, Pr

CONTACT

[email protected]

33+3 22 08 88 40

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: LOTUS

Important dates

Study start: 2022
Primary completion: 2026
Study completion: 2026
First posted: Feb 18, 2025
Registry last updated: Feb 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting